Search Results - clinton+ogega

2 Results

Sort By:

Human Broadly Neutralizing Monoclonal Antibodies associated with Hepatitis C Virus Clearance

Hepatitis C antibodies for the development of vaccinesJHU Ref #: C17709Value Proposition:· Comprehensive panel of monoclonal and broadly-neutralizing antibodies against HCV· Potential treatment for HCV infection· Key bNAb-E2 interactions identified· Candidates for discovery of HCV vaccine antigensUnmet NeedHepatitis C virus (HCV)...

Published: 12/11/2025 | Inventor(s): Justin Bailey, Clinton Ogega

Keywords(s):

Category(s): Clinical and Disease Specializations > Infectious Diseases > Hepatitis C Virus, Clinical and Disease Specializations > Infectious Diseases > Hepatitis C Virus (HCV), Technology Classifications > Therapeutic Modalities > Antibodies, Technology Classifications > Therapeutic Modalities > Therapeutic Antibodies, Technology Classifications > Therapeutic Modalities > Vaccines

A p105-based NF-(kappa) B Super repressor

C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...

Published: 12/11/2025 | Inventor(s): Li Lin

Keywords(s): Biologics, Cancers, Chemotherapy, Disease Indication, Nucleic Acid, Single, Skin Cancer, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Dermatology, Clinical and Disease Specializations > Oncology > Skin Cancer, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Proteins, Technology Classifications > Therapeutic Modalities > Targets, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities